Who Buys Fulvestrant from India — 148 Importers Behind a $14.6M Market
India's fulvestrant import market is served by 148 active buyers who collectively imported $14.6M across 487 shipments. YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) leads with a 10.2% market share, followed by J KNIPPER COMPANY and FARMAVENIX. The top 5 buyers together control 32.4% of total import value, reflecting a moderately competitive buyer landscape.
Top Fulvestrant Importers — Ranked by Import Value
YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) is the leading fulvestrant importer from India, holding a 10.2% share of the $14.6M market across 487 shipments from 148 buyers. The top 5 buyers — YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), J KNIPPER COMPANY (UNITED STATES), FARMAVENIX (SPAIN), ACCORD HEALTHCARE ITALIA SRL (ITALY), SOFTCARE INTERNATIONAL(PVT)LTD (SRI LANKA) — collectively control 32.4% of total import value.
Top Fulvestrant Buyers & Importers
Ranked by import value · 148 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | YUSEN LOGISTICS BENELUX BELGIUMBELGIUM FULVESTRANT INJECTION 250 MG/5 ML 50 MGFULVESTRANT INJ 250MG/5ML 1'S PFS IT PACFULVESTRANT INJ 250MG/5ML 2X1'S PFS GB P | $1.5M | 5 | 10.2% |
| 2 | J KNIPPER COMPANYUNITED STATES FULVESTRANT 250 MG/5 ML INJECTIONFULVESTRANT INJECTION 250MG/5ML 50MG/MLFULVESTRANT INJECTION 250 MG/5ML | $1.1M | 5 | 7.7% |
| 3 | FARMAVENIXSPAIN PHARMA DRUGS & MEDI:ONNIMIA FULVESTRANT | $744.9K | 5 | 5.1% |
| 4 | ACCORD HEALTHCARE ITALIA SRLITALY FULVESTRANT250MG/5MLINJPFS2SITFULVESTRANTO 250MG/5ML INJ PFS 2S BZLPHARMA DRUGS & MEDI FULVESTRANT PFS,250M | $723.0K | 5 | 4.9% |
| 5 | SOFTCARE INTERNATIONAL(PVT)LTDSRI LANKA FULVESTRANT INJECTION 250MG/5ML PRE-FILLED SYRINGE NOSFULVESTRANT INJECTION 250MG/5ML PRE-FILLED SYRINGEFULVESTRANT INJECTION 250 MG/5ML PRE-FILLED SYRINGE | $634.1K | 5 | 4.3% |
| 6 | XXNEAXXEU XXMITXXUNITED STATES FULVESTRANT 250 MG/5 ML INJECTIONFULVESTRANT INJECTION 250MG/5ML 50MG/MLFULVESTRANT INJECTION 250 MG/5ML | $625.2K | 5 | 4.3% |
| 7 | DR REDDYS LABORATORIES INCUNITED STATES FULVESTRANT 250 MG/5 ML INJECTIONFULVESTRANT INJECTION 250MG/5ML 50MG/MLFULVESTRANT INJECTION 250 MG/5ML | $595.3K | 5 | 4.1% |
| 8 | OOOJODAS EXPOIMRUSSIA FULVESTRANT INJECTION 250MG/5ML #1 | $462.1K | 5 | 3.2% |
| 9 | EUGIA PHARMA (MALTA) LTD,MALTA FULVESTRANT 250 MG/5 ML INJECTIONFULVESTRANT INJECTION 250MG/5ML 50MG/MLFULVESTRANT INJECTION 250 MG/5ML | $414.8K | 5 | 2.8% |
| 10 | BROCACEF NL : HUBNETHERLANDS PHARMA DRUGS & MEDI FULVESTRANT PFS,250MPHARMA DRUGS & MEDI:FULVESTRANT PFS,250M | $399.3K | 5 | 2.7% |
| 11 | AMERISOURCE HEALTH SERVICESUNITED STATES FULVESTRANT 250 MG/5 ML INJECTIONFULVESTRANT INJECTION 250MG/5ML 50MG/MLFULVESTRANT INJECTION 250 MG/5ML | $368.8K | 5 | 2.5% |
| 12 | ACCORD HEALTHCARE POLSKA SP. Z O.O.POLAND FULVESTRANT250MG/5MLINJPFS2SITFULVESTRANTO 250MG/5ML INJ PFS 2S BZLPHARMA DRUGS & MEDI FULVESTRANT PFS,250M | $357.5K | 5 | 2.4% |
| 13 | XX REXXY SXXABOXXTORXXS IXXUNITED STATES FULVESTRANT 250 MG/5 ML INJECTIONFULVESTRANT INJECTION 250MG/5ML 50MG/MLFULVESTRANT INJECTION 250 MG/5ML | $333.0K | 5 | 2.3% |
| 14 | DR REDDY S LABORATORIES INCUNITED STATES FULVESTRANT 250 MG/5 ML INJECTIONFULVESTRANT INJECTION 250MG/5ML 50MG/MLFULVESTRANT INJECTION 250 MG/5ML | $286.2K | 5 | 2.0% |
| 15 | EVERSANA LIFE SCIENCES SERVICES,LLCUNITED STATES FULVESTRANT 250 MG/5 ML INJECTIONFULVESTRANT INJECTION 250MG/5ML 50MG/MLFULVESTRANT INJECTION 250 MG/5ML | $270.6K | 5 | 1.9% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Fulvestrant — and from which countries?
Flow of Fulvestrant exports from India: each country's share and the named importers behind the numbers
Fulvestrant — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $4.4M through 23 shipments. This represents a market share of 30.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• J KNIPPER COMPANY - $1.1M (25.8% of country's total business)
• XXNEAXXEU XXMITXX - $625.2K (14.3% of country's total business)
• DR REDDYS LABORATORIES INC - $595.3K (13.6% of country's total business)
• AMERISOURCE HEALTH SERVICES - $368.8K (8.4% of country's total business)
• XX REXXY SXXABOXXTORXXS IXX - $333.0K (7.6% of country's total business)
• Rest of United States's importers - $1.3M (30.3% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $190.4K, indicating premium pricing strategy compared to the market average of $30.0K.
United States is a key market for Fulvestrant imports, representing 30.0% of total trade value.
2Belgium
Belgium emerges as the second largest importing country, achieving a total trade value of $1.5M through 19 shipments. This represents a market share of 10.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Belgium has a diverse importer base, with their top importers including:
• YUSEN LOGISTICS BENELUX BELGIUM - $1.5M (100.0% of country's total business)
Key Insight: Belgium demonstrates strong market positioning with an average shipment value of $78.8K, indicating premium pricing strategy compared to the market average of $30.0K.
Belgium is a key market for Fulvestrant imports, representing 10.2% of total trade value.
3Italy
Italy emerges as the third largest importing country, achieving a total trade value of $1.2M through 8 shipments. This represents a market share of 8.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Italy has a diverse importer base, with their top importers including:
• ACCORD HEALTHCARE ITALIA SRL - $723.0K (59.7% of country's total business)
Key Insight: Italy demonstrates strong market positioning with an average shipment value of $151.4K, indicating premium pricing strategy compared to the market average of $30.0K.
Italy is a key market for Fulvestrant imports, representing 8.3% of total trade value.
4Netherlands
Netherlands emerges as the fourth largest importing country, achieving a total trade value of $989.4K through 14 shipments. This represents a market share of 6.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Netherlands has a diverse importer base, with their top importers including:
• BROCACEF NL : HUB - $399.3K (40.4% of country's total business)
Key Insight: Netherlands demonstrates strong market positioning with an average shipment value of $70.7K, indicating premium pricing strategy compared to the market average of $30.0K.
Netherlands is a key market for Fulvestrant imports, representing 6.8% of total trade value.
5Russia
Russia emerges as the fifth largest importing country, achieving a total trade value of $981.1K through 2 shipments. This represents a market share of 6.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Russia has a diverse importer base, with their top importers including:
• OOOJODAS EXPOIM - $462.1K (47.1% of country's total business)
Key Insight: Russia demonstrates strong market positioning with an average shipment value of $490.5K, indicating premium pricing strategy compared to the market average of $30.0K.
Russia is a key market for Fulvestrant imports, representing 6.7% of total trade value.
Buyer Segment Analysis
TransData Nexus Fulvestrant buyer market intelligence
1Buyer Segment Analysis
The 148 buyers of Fulvestrant imported from India can be categorized into several segments:
1. Distributors: Entities that purchase Fulvestrant in bulk to supply to various healthcare providers.
2. Re-exporters: Companies that import Fulvestrant for the purpose of exporting it to other markets.
3. Contract Manufacturers: Organizations that import Fulvestrant as an active pharmaceutical ingredient (API) for formulation and packaging.
4. Government Procurement Agencies: Public sector entities responsible for acquiring medications for national healthcare programs.
The repeat buyer rate of 45.9% indicates a significant level of ongoing demand and satisfaction among these segments, reflecting the critical role Fulvestrant plays in their respective operations.
Country-Specific Import Regulations
TransData Nexus Fulvestrant buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Fulvestrant are as follows:
1. United States:
2. Belgium:
3. Italy:
4. Netherlands:
5. Russia:
Demand Drivers & Market Opportunity
TransData Nexus Fulvestrant buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Fulvestrant in importing countries is driven by several factors:
1. Disease Prevalence: Fulvestrant is primarily used in the treatment of hormone receptor-positive metastatic breast cancer. According to the World Health Organization (WHO), breast cancer remains the most common cancer among women worldwide, with approximately 2.3 million new cases diagnosed in 2020.
2. Government Healthcare Programs: Many countries have national healthcare programs that subsidize or fully cover the cost of essential medicines, including cancer treatments like Fulvestrant. For instance, the European Union's Cross-Border Healthcare Directive facilitates patient access to treatments across member states.
3. Universal Health Coverage Expansion: Countries are increasingly striving to achieve universal health coverage, ensuring that all individuals have access to necessary health services without financial hardship. This expansion often includes the provision of essential cancer medications.
4. WHO Essential Medicines List Procurement: While Fulvestrant is not currently listed on the WHO Model List of Essential Medicines, its inclusion in national essential medicines lists can influence procurement decisions, especially in low- and middle-income countries.
5. Tender-Based Purchasing: Government and large healthcare organizations often procure medicines through tendering processes to ensure cost-effectiveness and supply security. This approach can lead to competitive pricing and stable demand for Fulvestrant. (iris.who.int)
The presence of 148 buyers across 66 countries underscores the global demand for Fulvestrant. This widespread procurement indicates a robust market opportunity, particularly in regions with high breast cancer incidence and strong governmental support for cancer treatment programs.
Common Questions — Fulvestrant Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest fulvestrant buyer importing from India?
Based on import volume and value, YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) leads with $1.5M in imports and a 10.2% market share — the highest of any single fulvestrant importer. J KNIPPER COMPANY (UNITED STATES) and FARMAVENIX (SPAIN) are the next largest buyers.
QHow many companies buy fulvestrant from India?
There are 148 active fulvestrant buyers importing from India, with a combined market of $14.6M across 487 shipments to 66 countries. The top 5 buyers hold 32.4% of total import value, while the remaining 143 buyers handle the other 67.6%.
QWhich countries import the most fulvestrant from India?
The top importing countries for fulvestrant from India are United States (30.0%), Belgium (10.2%), Italy (8.3%), Netherlands (6.8%), Russia (6.7%). These markets represent the largest demand centres for Indian pharmaceutical exports of fulvestrant, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for fulvestrant from India?
The average import transaction value for fulvestrant from India is $30.0K, with an average unit price of $45.94 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Fulvestrant buyer market intelligence
1Buyer Segment Analysis
The 148 buyers of Fulvestrant imported from India can be categorized into several segments:
1. Distributors: Entities that purchase Fulvestrant in bulk to supply to various healthcare providers.
2. Re-exporters: Companies that import Fulvestrant for the purpose of exporting it to other markets.
3. Contract Manufacturers: Organizations that import Fulvestrant as an active pharmaceutical ingredient (API) for formulation and packaging.
4. Government Procurement Agencies: Public sector entities responsible for acquiring medications for national healthcare programs.
The repeat buyer rate of 45.9% indicates a significant level of ongoing demand and satisfaction among these segments, reflecting the critical role Fulvestrant plays in their respective operations.
Country-Specific Import Regulations
TransData Nexus Fulvestrant buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Fulvestrant are as follows:
1. United States:
2. Belgium:
3. Italy:
4. Netherlands:
5. Russia:
Demand Drivers & Market Opportunity
TransData Nexus Fulvestrant buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Fulvestrant in importing countries is driven by several factors:
1. Disease Prevalence: Fulvestrant is primarily used in the treatment of hormone receptor-positive metastatic breast cancer. According to the World Health Organization (WHO), breast cancer remains the most common cancer among women worldwide, with approximately 2.3 million new cases diagnosed in 2020.
2. Government Healthcare Programs: Many countries have national healthcare programs that subsidize or fully cover the cost of essential medicines, including cancer treatments like Fulvestrant. For instance, the European Union's Cross-Border Healthcare Directive facilitates patient access to treatments across member states.
3. Universal Health Coverage Expansion: Countries are increasingly striving to achieve universal health coverage, ensuring that all individuals have access to necessary health services without financial hardship. This expansion often includes the provision of essential cancer medications.
4. WHO Essential Medicines List Procurement: While Fulvestrant is not currently listed on the WHO Model List of Essential Medicines, its inclusion in national essential medicines lists can influence procurement decisions, especially in low- and middle-income countries.
5. Tender-Based Purchasing: Government and large healthcare organizations often procure medicines through tendering processes to ensure cost-effectiveness and supply security. This approach can lead to competitive pricing and stable demand for Fulvestrant. (iris.who.int)
The presence of 148 buyers across 66 countries underscores the global demand for Fulvestrant. This widespread procurement indicates a robust market opportunity, particularly in regions with high breast cancer incidence and strong governmental support for cancer treatment programs.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 148 global importers of Fulvestrant identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 487 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 66 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
487 Verified Shipments
148 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists